February 20, 2026 What Collaboration Makes Possible On a Tuesday afternoon in the fall of 2019, a biostatistician from a pharmaceutical company...
February 12, 2026 Building the Infrastructure of Hope Medical history is usually written as a chronicle of individual breakthroughs. We learn about Fleming discovering penicillin...
February 10, 2026 The Critical Path Institute Podcast: Electronic Clinical Outcome Assessments in Oncology Research This panel discussion, hosted by C-Path's Electronic Clinical Outcome Assessment Executive Director Scottie Kern...
February 1, 2026 Turning the Impossible into the POSSIBLE February is Rare Disease Month. It is a time when the global community unites to support the 350 million people worldwide...
January 28, 2026 C-Path’s New Clinical Pharmacology & Therapeutics Publication Highlights Real-World Impact of FDA-Qualified Urine Biomarkers for Earlier Detection of Drug-Induced Kidney Injury C-Path) Predictive Safety Testing Consortium today announced the publication of a new peer-reviewed...
January 21, 2026 C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators Included is a dedicated polycystic kidney disease track alongside investments in brain health, pediatrics, and rare diseases. TUCS
January 13, 2026 20 Years of Innovation: Reflecting on C-Path’s Legacy and Looking Ahead, Pt. 2 C-Path's newest podcast episode picks up on the 20th Anniversary commemoration and provides an insight...
January 27, 2026 Join C-Path’s 2026 Translational Therapeutics Accelerator Funding Opportunities Webinar On Tuesday, January 27, 2026, C-Path's Translational Therapeutics Accelerator will host the 2026 Funding...
December 17, 2025 The Critical Path Institute Podcast: 20 Years of Impact Reflect on C-Path’s Legacy and a Look Ahead, Pt. 1 This C-Path podcast episode celebrates C-Path's 20 years of impactful innovation, and looks at the future of...
December 1, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q4 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements, webinars...